Walpar Nutritions reports 16% rise in FY26 consolidated net profit

1 min read     Updated on 29 May 2026, 12:11 PM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Walpar Nutritions Limited reported a 16% increase in consolidated net profit to ₹320.70 lakh for FY26, with total revenue rising to ₹7904.97 lakh. The Board approved the audited financial results on May 28, 2026. Standalone net profit grew to ₹196.53 lakh, and revenue from operations reached ₹6529.88 lakh.

powered bylight_fuzz_icon
41582383

*this image is generated using AI for illustrative purposes only.

Walpar Nutritions Limited reported a 16% increase in consolidated net profit to ₹320.70 lakh for the financial year ended March 31, 2026, compared to ₹279.81 lakh in the previous year. The company's total revenue for the year stood at ₹7904.97 lakh, up from ₹7202.93 lakh in FY25. The Board of Directors approved the audited financial results and appointed new auditors at a meeting held on May 28, 2026.

On a standalone basis, the company recorded a net profit of ₹196.53 lakh for FY26, compared to ₹169.26 lakh in the corresponding period of the previous year. Revenue from operations for the standalone entity increased to ₹6529.88 lakh from ₹6016.16 lakh in FY25. The statutory auditors, A Y & Company, issued an unmodified opinion on the financial results.

Consolidated Financial Performance

The consolidated financial results include the performance of subsidiaries Walpar Wellness Private Limited and Walpar Nutri Science Private Limited, as well as associate company Pallota Nutritions Private Limited. Profit attributable to the owners of the parent rose to ₹247.44 lakh for the year ended March 31, 2026, from ₹232.44 lakh in the prior year.

Metric FY26 (₹ in Lakhs) FY25 (₹ in Lakhs)
Total Revenue 7904.97 7202.93
Total Expenses 7494.66 6815.14
Profit Before Tax 410.31 387.79
Net Profit 320.70 279.81
Earnings Per Share (Basic) 2.64 2.48

Assets and Liabilities

The consolidated total assets as of March 31, 2026, stood at ₹6607.20 lakh, an increase from ₹4738.65 lakh in the previous year. Shareholders' funds grew to ₹1890.00 lakh, comprising share capital of ₹939.04 lakh and reserves of ₹950.96 lakh. The company reported no outstanding defaults on loans or debt securities as of the reporting date.

Segment Reporting

The company operates in a single primary segment focused on the manufacturing and trading of pharmaceutical, nutraceutical, herbal, and Ayurvedic commodities. Consequently, segment-wise reporting in accordance with Accounting Standard 17 is not applicable. There were no investor complaints pending as of March 31, 2026.

Historical Stock Returns for Walpar Nutritions

1 Day5 Days1 Month6 Months1 Year5 Years
-4.92%-9.24%-19.05%-27.39%-38.56%-47.46%

What strategic initiatives will Walpar Nutritions pursue to sustain the double-digit revenue growth observed in FY26?

How does the company plan to utilize the significant increase in consolidated total assets to drive future expansion?

Will the company consider declaring dividends in the upcoming fiscal year given the growth in shareholders' funds and net profit?

Three Walpar Nutritions directors resign effective May 19

1 min read     Updated on 23 May 2026, 06:39 PM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Walpar Nutritions Limited announced the resignation of three Executive Directors, Mr. Krunal Jashubhai Patel, Mr. Jigneshkumar Dineshkumar Modi, and Mr. Abhishekkumar Dineshkumar Patel, effective May 19, 2026. The resignations were attributed to pre-occupation and a lack of time to devote to company affairs. The company confirmed compliance with Regulation 30 of the Listing Regulations.

powered bylight_fuzz_icon
40798884

*this image is generated using AI for illustrative purposes only.

Walpar Nutritions Limited has informed the exchanges regarding the resignation of three Executive Directors from its board. The resignations of Mr. Krunal Jashubhai Patel, Mr. Jigneshkumar Dineshkumar Modi, and Mr. Abhishekkumar Dineshkumar Patel are effective May 19, 2026. The company disclosed that the changes were made in compliance with Regulation 30 of the Listing Regulations.

Resignation Details

The departing officials have confirmed that their decision to step down is due to pre-occupation. In their respective resignation letters, each director stated they are no longer in a position to devote sufficient time to the affairs of the company. Consequently, they submitted their resignations with immediate effect.

The directors further confirmed that there are no other material reasons for their resignations beyond those stated in their letters. None of the resigning directors currently hold directorships in other listed entities or serve on the board committees of any listed entities.

Summary of Resignations

The following table summarizes the key details of the board changes:

Name Designation Date of Cessation Reason
Mr. Krunal Jashubhai Patel Executive Director May 19, 2026 Due to pre-occupation
Mr. Jigneshkumar Dineshkumar Modi Executive Director May 19, 2026 Due to pre-occupation
Mr. Abhishekkumar Dineshkumar Patel Executive Director May 19, 2026 Due to pre-occupation

The board has accepted the resignations, and the necessary updates to the company's records will be made accordingly.

Historical Stock Returns for Walpar Nutritions

1 Day5 Days1 Month6 Months1 Year5 Years
-4.92%-9.24%-19.05%-27.39%-38.56%-47.46%

How will Walpar Nutritions Limited identify and onboard replacement Executive Directors, and what timeline can investors expect for restoring full board strength?

Could the simultaneous resignation of three Executive Directors signal deeper operational or financial challenges within Walpar Nutritions Limited that may surface in upcoming quarterly results?

How might this significant board-level disruption impact Walpar Nutritions' strategic initiatives, partnerships, or expansion plans in the near term?

1 Year Returns:-38.56%